Lyell Immunopharma Growth Metrics (2020-2026) | LYEL

Growth Metrics Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)
0.09M0.17M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M-29.88M-139.35M
EBITDA Margin Growth (3y) (Quarter)
-24.08M-23.27M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M-212.74M-211.68M
EBITDA Margin Growth (5y) (Quarter)
-58.60M-24.49M-212.57M-221.08M
EBITDA Margin (QoQ) (Quarter)
-0.01M0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M-187.90M-8.56M
EBIT Margin Growth (1y) (Quarter)
0.09M0.17M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M-29.88M-139.35M
EBIT Margin Growth (3y) (Quarter)
-24.08M-23.27M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M-212.74M-211.68M
EBIT Margin Growth (5y) (Quarter)
-58.60M-24.49M-212.57M-221.08M
EBIT Margin (QoQ) (Quarter)
-0.01M0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M-187.90M-8.56M
EBT Margin Growth (1y) (Quarter)
-0.33M0.13M0.00M-2.94M0.63M-627.71M0.59M-9.65M-33.60M599.91M-235.99M-236.88M-65.97M-8.57M-274.02M65.58M-44.73M-31.52M268.90M-331.96M
EBT Margin Growth (3y) (Quarter)
-33.30M-27.67M-235.40M-249.47M-98.94M-36.37M-509.43M-180.95M-144.30M559.81M-241.12M-503.26M
EBT Margin Growth (5y) (Quarter)
-144.01M-67.76M-240.53M-515.85M
EBT Margin (QoQ) (Quarter)
-0.43M0.44M-0.40M-2.55M3.13M-627.89M627.89M-12.78M-20.82M5.61M-208.01M-13.67M150.10M63.01M-473.46M325.93M39.78M76.22M-173.04M-274.93M
Enterprise Value Growth (1y) (Quarter)
-234.60%-358.87%-0.36%-151.22%20.49%-4.72%-4.12%0.19%9.12%11.22%14.67%14.11%17.56%23.44%32.17%42.77%43.64%27.45%33.28%15.66%
Enterprise Value Growth (3y) (Quarter)
-34.21%-62.19%3.75%-29.14%15.86%10.71%15.53%21.13%24.98%20.99%27.18%25.44%
Enterprise Value Growth (5y) (Quarter)
-2.35%-18.83%16.60%-0.78%
Enterprise Value (QoQ) (Quarter)
-237.41%24.94%0.67%0.14%-6.78%1.13%1.23%4.28%2.78%3.41%5.08%3.65%6.68%10.30%15.89%18.72%8.10%-15.48%22.65%-2.75%
FCF Margin Growth (1y) (Quarter)
0.23M-0.07M-0.67M0.09M-177.39M0.33M-6.48M-14.84M163.39M-33.32M-132.81M-14.47M3.67M-9.37M61.73M-14.08M-8.36M-12.36M-114.58M
FCF Margin Growth (3y) (Quarter)
-13.77M-33.06M-139.96M-29.22M-10.33M-42.37M-77.55M-43.38M158.70M-55.05M-185.65M
FCF Margin Growth (5y) (Quarter)
-18.46M-54.79M-192.80M
FCF Margin (QoQ) (Quarter)
0.09M0.01M-0.24M-0.54M0.85M-177.47M177.48M-7.34M-7.50M0.76M-19.23M-106.83M110.83M18.90M-32.28M-35.72M35.02M24.62M-36.28M-137.94M
Interest Coverage Ratio Growth (1y) (Quarter)
5.25%27.42%87.25%78.03%-279.51%-509.42%-775.59%-191.87%-14.29%73.52%86.09%-133.61%72.49%-4.53%14.90%-1,234.66%6.18%
Interest Coverage Ratio Growth (3y) (Quarter)
15.31%-5.41%46.25%-14.41%-6.06%-19.04%-1.21%-349.80%33.43%
Interest Coverage Ratio Growth (5y) (Quarter)
-80.08%
Interest Coverage Ratio (QoQ) (Quarter)
-667.65%91.38%-80.26%39.18%-34.83%85.14%-3,014.45%2.34%-93.71%95.05%-1,119.52%77.37%-1.80%16.83%-43.61%14.02%17.13%-1,204.38%89.91%
Net Margin Growth (1y) (Quarter)
-0.33M0.13M0.00M-2.94M0.63M-627.71M0.59M-9.65M-33.60M599.91M-235.99M-236.88M-65.97M-8.57M-274.02M65.58M-44.73M-31.52M268.90M-331.96M
Net Margin Growth (3y) (Quarter)
-33.30M-27.67M-235.40M-249.47M-98.94M-36.37M-509.43M-180.95M-144.30M559.81M-241.12M-503.26M
Net Margin Growth (5y) (Quarter)
-144.01M-67.76M-240.53M-515.85M
Net Margin (QoQ) (Quarter)
-0.43M0.44M-0.40M-2.55M3.13M-627.89M627.89M-12.78M-20.82M5.61M-208.01M-13.67M150.10M63.01M-473.46M325.93M39.78M76.22M-173.04M-274.93M
Operating Margin Growth (1y) (Quarter)
0.09M0.17M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M-29.88M-139.35M
Operating Margin Growth (3y) (Quarter)
-24.08M-23.27M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M-212.74M-211.68M
Operating Margin Growth (5y) (Quarter)
-58.60M-24.49M-212.57M-221.08M
Operating Margin (QoQ) (Quarter)
-0.01M0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M-187.90M-8.56M
Return on Assets Growth (1y) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-1.00-1.00-1.00-1.000.00M1.00
Return on Assets Growth (3y) (Quarter)
-1.00-1.00-2.00-2.00-2.00-1.00-1.00
Return on Assets (QoQ) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-1.000.00M0.00M0.00M1.000.00M
Return on Capital Employed Growth (1y) (Quarter)
-528.00-108.0092.00-514.00-275.00-0.00M-0.00M-961.00-0.00M-0.00M-0.01M-0.01M-0.01M-0.00M293.00
Return on Capital Employed Growth (3y) (Quarter)
-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M
Return on Capital Employed (QoQ) (Quarter)
-134.00-229.00121.00-286.00286.00-29.00-485.00-47.00-754.00-133.00-28.00-92.00-0.00M-0.00M-0.00M208.000.00M-11.00
Return on Sales Growth (1y) (Quarter)
-33.0013.000.00M-294.0063.00-0.06M59.00-965.00-0.00M0.06M-0.02M-0.02M-0.01M-857.00-0.03M0.01M-0.00M-0.00M0.03M-0.03M
Return on Sales Growth (3y) (Quarter)
-0.00M-0.00M-0.02M-0.02M-0.01M-0.00M-0.05M-0.02M-0.01M0.06M-0.02M-0.05M
Return on Sales Growth (5y) (Quarter)
-0.01M-0.01M-0.02M-0.05M
Return on Sales (QoQ) (Quarter)
-43.0044.00-40.00-255.00313.00-0.06M0.06M-0.00M-0.00M561.00-0.02M-0.00M0.02M0.01M-0.05M0.03M0.00M0.01M-0.02M-0.03M